Remifentanil

Generic Name
Remifentanil
Brand Names
Ultiva
Drug Type
Small Molecule
Chemical Formula
C20H28N2O5
CAS Number
132875-61-7
Unique Ingredient Identifier
P10582JYYK
Background

Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

Indication

For use during the induction and maintenance of general anesthesia.

Associated Conditions
-
Associated Therapies
Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation

The Effect of Lidocaine on Smooth Emergence With Double Lumen Tube

Not Applicable
Conditions
Interventions
First Posted Date
2020-07-02
Last Posted Date
2020-07-02
Lead Sponsor
Ajou University School of Medicine
Target Recruit Count
80
Registration Number
NCT04455711
Locations
🇰🇷

Ajou University Hospital, Suwon, Gyeonggido, Korea, Republic of

Inflammatory Effect Comparison Between Fentanyl and Remifentanil in Mastectomy Under General Anesthesia

First Posted Date
2020-06-17
Last Posted Date
2021-06-02
Lead Sponsor
Udayana University
Target Recruit Count
48
Registration Number
NCT04435925
Locations
🇮🇩

Sanglah General Hospital, Denpasar, Bali, Indonesia

Drip-infusion of Remifentanil for RIH

Completed
Conditions
Interventions
First Posted Date
2020-05-13
Last Posted Date
2020-05-15
Lead Sponsor
Tri-Service General Hospital
Target Recruit Count
559
Registration Number
NCT04387097
Locations
🇨🇳

TriService General Hospital, Taipei, Taiwan

The Effect of Analgesic Drugs on Respiratory Center

First Posted Date
2020-05-04
Last Posted Date
2020-05-04
Lead Sponsor
Chun Pan
Target Recruit Count
50
Registration Number
NCT04372342
Locations
🇨🇳

Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China

Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results in Children

Not Applicable
Active, not recruiting
Conditions
Interventions
First Posted Date
2020-04-28
Last Posted Date
2024-11-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
400
Registration Number
NCT04364945
Locations
🇰🇷

Seoul National University Hospital, Seoul, Other, Korea, Republic of

Totally Transdermal Sedation in the Weaning From Remifentanil Infusion

First Posted Date
2019-12-19
Last Posted Date
2024-05-17
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Target Recruit Count
24
Registration Number
NCT04204967
Locations
🇮🇹

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

Remifentanil Versus Fentanyl During Laparoscopic Hysterectomy

Not Applicable
Conditions
Interventions
First Posted Date
2019-11-26
Last Posted Date
2019-11-26
Lead Sponsor
Wolfson Medical Center
Target Recruit Count
76
Registration Number
NCT04178785
Locations
🇮🇱

Wolfson medical center, Holon, Israel

Dexmedetomidine Sedation in Orthopedic Surgery

First Posted Date
2019-11-04
Last Posted Date
2020-01-30
Lead Sponsor
Asklepieion Voulas General Hospital
Target Recruit Count
60
Registration Number
NCT04149626
Locations
🇬🇷

Asklepieion Hospital of Voula, Athens, Greece

Opioid Free Anesthesia in ENT Surgery

First Posted Date
2019-09-26
Last Posted Date
2022-08-19
Lead Sponsor
University of Thessaly
Target Recruit Count
200
Registration Number
NCT04105946
Locations
🇬🇷

Univeristy of Thessaly, Larissa, Thessaly, Greece

Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults

First Posted Date
2019-08-16
Last Posted Date
2020-10-19
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
21
Registration Number
NCT04059978
Locations
🇨🇭

Department of Anaesthesiology, University Hospital of Basel (USB), Basel, Switzerland

© Copyright 2024. All Rights Reserved by MedPath